-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on MBX Biosciences, Raises Price Target to $50

Benzinga·12/19/2025 14:44:11
Listen to the news
Stifel analyst Annabel Samimy maintains MBX Biosciences (NASDAQ:MBX) with a Buy and raises the price target from $45 to $50.